Ryan Kelley v. HHS - tetanus toxoid, Guillain-Barre syndrome, later categorized as chronic inflammatory demyelinating polyneuropathy (CIDP) (2005)
Case summary [AI summaries can sometimes make mistakes]
On March 21, 2002, Ryan Kelley's father filed a petition under the National Vaccine Injury Compensation Program alleging that a tetanus toxoid (TT) booster Ryan received on March 22, 1999, caused a neurological injury. Ryan, then fourteen years old, had recently passed a physical for his high school tennis team, with his pediatrician noting him as a healthy young man.
Approximately two weeks after the vaccination, Ryan began experiencing progressive numbness and tingling in his hands and feet, dizziness, headaches, a low-grade fever, joint and neck pain, and fatigue. His condition led to further medical evaluations, including by pediatric neurologist Dr.
Nallainathan, who initially diagnosed an atypical form of Guillain-Barré syndrome (GBS). Dr.
Nallainathan noted the recent TT vaccination and referenced literature suggesting a link between tetanus toxoid and GBS-type illness, agreeing with Professor Gerald Fenichel that Ryan's condition was likely an atypical GBS secondary to the tetanus toxoid and advising against future TT vaccinations. Ryan showed improvement after a short course of steroids, but his condition did not resolve like a typical acute GBS case.
By August 1999, Dr. Nallainathan reclassified Ryan's condition as chronic inflammatory demyelinating polyneuropathy (CIDP).
Ryan was later evaluated by Johns Hopkins neurologist Dr. David Cornblath, who described a difficult neuromuscular problem, noting that after the TT injection, Ryan developed an acquired demyelinating neuropathy.
Dr. Cornblath's differential diagnoses included GBS, CIDP, CIDP with a paraprotein, or CIDP following tetanus administration.
After two years of largely unsuccessful treatment, Dr. Cornblath described Ryan as having a severe acquired demyelinating neuropathy, slightly worse than when first seen.
The petition, initially alleging GBS and CIDP, was amended to allege GBS with residual effects lasting more than six months. After Ryan reached adulthood, he became the sole petitioner.
The chief special master heard testimony from petitioner's expert, Dr. Carlo Tornatore, and respondent's expert, Dr.
Vinay Chaudhry. Dr.
Tornatore opined that the TT vaccination caused Ryan's inflammatory neuropathy, arguing that acute inflammatory neuropathy can become chronic and that distinctions between relapsing, progressive, and chronic inflammatory demyelinating polyneuropathies are artificial for immune process purposes. Respondent contended that GBS and CIDP are distinct diseases and that literature linking TT to GBS could not be used to prove TT caused CIDP.
The chief special master initially denied compensation in October 2004, reopened the case for supplemental evidence, and again denied compensation on March 17, 2005. The chief special master concluded that the medical records and expert testimony supported a diagnosis of CIDP rather than GBS, and that petitioner had not proven that TT can cause CIDP or that GBS and CIDP are similar enough for GBS causation evidence to apply to CIDP.
On August 31, 2005, Judge Hewitt reversed this decision. The court found the case analogous to the Federal Circuit's Althen decision, which relaxed requirements for objective medical literature proof in off-Table causation cases.
The court held that the chief special master had improperly demanded conclusive proof of TT causing CIDP, overlooking the Vaccine Act's allowance for causation to be shown by medical opinion, circumstantial evidence, logical sequence, and medically appropriate timing. The court emphasized the strong temporal relationship, the treating physicians' consideration of TT as a possible cause, the absence of another identified cause, and Dr.
Tornatore's opinion that the TT booster was the causal trigger. The court granted Ryan's motion for review, reversed the chief special master's dismissal, and remanded the case for an award of compensation, establishing entitlement based on the TT vaccination being a substantial factor in causing his demyelinating neuropathy.
The final award amount is not stated in the provided text.
Theory of causation
Petitioner Ryan Kelley, age 14, received a tetanus toxoid (TT) booster on March 22, 1999. Approximately two weeks later, he developed progressive neurological symptoms, initially diagnosed as atypical Guillain-Barré syndrome (GBS) and later as chronic inflammatory demyelinating polyneuropathy (CIDP). Petitioner alleged the TT vaccination caused his condition. Petitioner's expert, Dr. Carlo Tornatore, opined that TT caused Ryan's inflammatory neuropathy, arguing GBS and CIDP are part of a related inflammatory spectrum and that acute immune neuropathy can become chronic. Respondent argued GBS and CIDP are distinct diseases and TT causation evidence for GBS does not apply to CIDP. Treating physicians, including Dr. Nallainathan and Dr. David Cornblath, noted the temporal relationship and considered TT as a potential cause. Dr. Nallainathan diagnosed atypical GBS and noted literature linking TT to GBS-type illness. Dr. Cornblath diagnosed acquired demyelinating neuropathy following TT and included CIDP following tetanus administration in his differential diagnosis. No alternative cause was identified. The chief special master denied compensation, finding insufficient evidence that TT causes CIDP and that GBS and CIDP are sufficiently similar for GBS causation evidence to apply. On review, Judge Hewitt reversed, finding the chief special master applied an overly rigorous standard of proof, contrary to the Althen decision. The court held that causation could be established by medical opinion, circumstantial evidence, logical sequence, and medically appropriate timing, emphasizing the strong temporal relationship, treating physicians' opinions, absence of alternative causes, and Dr. Tornatore's expert opinion. The case was remanded for an award of compensation, establishing entitlement. Attorneys for petitioner and respondent are not named in the provided text. The decision date was August 31, 2005. The petition was filed March 21, 2002, and amended November 5, 2002. The award amount is not stated in the provided text.
Source PDFs
USCOURTS-cofc-1_02-vv-00223